Horst Christian Weber, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Bombesin | 4 | 2012 | 27 | 1.240 |
Why?
|
| Bombesin | 2 | 2011 | 35 | 0.630 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2022 | 454 | 0.570 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 1206 | 0.430 |
Why?
|
| Gastrin-Releasing Peptide | 2 | 2012 | 36 | 0.420 |
Why?
|
| Chalcone | 1 | 2011 | 10 | 0.390 |
Why?
|
| Appetite Depressants | 1 | 2012 | 108 | 0.380 |
Why?
|
| Cyclohexanes | 1 | 2011 | 151 | 0.380 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2011 | 185 | 0.370 |
Why?
|
| Somatostatin | 1 | 2013 | 458 | 0.360 |
Why?
|
| Cathepsins | 1 | 2011 | 243 | 0.360 |
Why?
|
| Peptide Hormones | 1 | 2011 | 132 | 0.340 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 101 | 0.330 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 371 | 0.270 |
Why?
|
| Obesity | 2 | 2024 | 13090 | 0.270 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 659 | 0.260 |
Why?
|
| Sirolimus | 1 | 2013 | 1540 | 0.250 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2005 | 133 | 0.250 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2013 | 957 | 0.240 |
Why?
|
| Cyclin D1 | 1 | 2005 | 453 | 0.220 |
Why?
|
| Biological Products | 1 | 2011 | 948 | 0.200 |
Why?
|
| Fermentation | 1 | 2022 | 143 | 0.190 |
Why?
|
| Appetite Regulation | 2 | 2012 | 84 | 0.180 |
Why?
|
| Oligosaccharides | 1 | 2022 | 407 | 0.170 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 13676 | 0.160 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2022 | 263 | 0.160 |
Why?
|
| Prostatic Neoplasms | 3 | 2011 | 11101 | 0.150 |
Why?
|
| Hepatitis B Antibodies | 1 | 2018 | 156 | 0.140 |
Why?
|
| Hepatitis B Vaccines | 1 | 2018 | 178 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 5446 | 0.120 |
Why?
|
| Homeostasis | 3 | 2012 | 3348 | 0.120 |
Why?
|
| Mammals | 2 | 2011 | 1135 | 0.110 |
Why?
|
| Satiety Response | 1 | 2012 | 47 | 0.100 |
Why?
|
| Chalcones | 1 | 2011 | 32 | 0.100 |
Why?
|
| Hormone Antagonists | 1 | 2011 | 108 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 4620 | 0.080 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2010 | 69 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2012 | 2907 | 0.080 |
Why?
|
| Metabolism | 1 | 2011 | 193 | 0.080 |
Why?
|
| Peptide YY | 1 | 2010 | 135 | 0.080 |
Why?
|
| Rodentia | 1 | 2011 | 262 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2010 | 92 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 542 | 0.080 |
Why?
|
| Neuropeptide Y | 1 | 2010 | 194 | 0.080 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2013 | 879 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13586 | 0.070 |
Why?
|
| Ghrelin | 1 | 2010 | 251 | 0.070 |
Why?
|
| Appetite | 1 | 2010 | 247 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12252 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2013 | 23645 | 0.070 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2010 | 374 | 0.070 |
Why?
|
| Diet | 1 | 2022 | 8089 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2062 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2011 | 2932 | 0.050 |
Why?
|
| Animals | 6 | 2013 | 169246 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2442 | 0.050 |
Why?
|
| Humans | 13 | 2024 | 768166 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 1088 | 0.050 |
Why?
|
| Serotonin Antagonists | 1 | 2003 | 147 | 0.050 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6847 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 17140 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 13490 | 0.050 |
Why?
|
| Carbolines | 1 | 2003 | 295 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1750 | 0.040 |
Why?
|
| Bacteriophage P1 | 1 | 1998 | 10 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 1494 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2003 | 511 | 0.040 |
Why?
|
| Transfection | 1 | 2005 | 5755 | 0.040 |
Why?
|
| Mice | 3 | 2013 | 82029 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6430 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1998 | 275 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 1998 | 115 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 11928 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14488 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1998 | 414 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 458 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10399 | 0.030 |
Why?
|
| Apoptosis | 1 | 2011 | 9523 | 0.030 |
Why?
|
| X Chromosome | 1 | 1998 | 819 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5797 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 533 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2179 | 0.030 |
Why?
|
| Protein Binding | 1 | 2005 | 9343 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2018 | 1393 | 0.030 |
Why?
|
| Male | 6 | 2018 | 364719 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4168 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 2521 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2005 | 12800 | 0.020 |
Why?
|
| Gene Deletion | 1 | 1998 | 2675 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1998 | 1885 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6082 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1596 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1998 | 2810 | 0.020 |
Why?
|
| Base Sequence | 1 | 1998 | 12421 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 4786 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4352 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 13421 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 17622 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12077 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13290 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2003 | 45 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 22371 | 0.010 |
Why?
|
| Serotonin | 1 | 2003 | 1043 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 663 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 1673 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 1998 | 1120 | 0.010 |
Why?
|
| Haplotypes | 1 | 1998 | 2722 | 0.010 |
Why?
|
| Pedigree | 1 | 1998 | 4539 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 81762 | 0.000 |
Why?
|
| Sex Factors | 1 | 2003 | 10632 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 8054 | 0.000 |
Why?
|
| Female | 3 | 2018 | 397192 | 0.000 |
Why?
|
| Middle Aged | 1 | 2018 | 223492 | 0.000 |
Why?
|
| United States | 1 | 2003 | 73039 | 0.000 |
Why?
|